Intraoperative neural monitoring (IONM) during thyroid and parathyroid surgery has gained widespread acceptance as an adjunct to the gold standard of visual nerve identification. Despite the increasing use of IONM, review of the literature and clinical experience confirms there is little uniformity in application of and results from nerve monitoring across different centers. We provide a review of the literature and cumulative experience of the multidisciplinary International Neural Monitoring Study Group with IONM spanning nearly 15 years. The study group focused its initial work on formulation of standards in IONM as it relates to important areas: 1) standards of equipment setup/endotracheal tube placement and 2) standards of loss of signal evaluation/intraoperative problemsolving algorithm. The use of standardized methods and reporting will provide greater uniformity in application of IONM. In addition, this report clarifies the limitations of IONM and helps identify areas where additional research is necessary. This guideline is, at its forefront, quality driven; it is intended to improve the quality of neural monitoring, to translate the best available evidence into clinical practice to promote best practices. We hope this work will minimize inappropriate variations in monitoring rather than to dictate practice options.

Intraoperative neurophysiologic monitoring (INM) using somatosensory and motor evoked potentials (MEPs) has become popular to reduce neural risk and to improve intraoperative surgical decision making. Intraoperative neurophysiologic monitoring is affected by the choice and management of the anesthetic agents chosen. Because inhalational and intravenous anesthetic agents have effects on neural synaptic and axonal functional activities, the anesthetic effect on any given response will depend on the pathway affected and the mechanism of action of the anesthetic agent (i.e., direct inhibition or indirect effects based on changes in the balance of inhibitory or excitatory inputs). In general, responses that are more highly dependent on synaptic function will have more marked reductions in amplitude and increases in latency as a result of the synaptic effects of inhalational anesthetic agents and similar effects at higher doses of intravenous agents. Hence, recording cortical somatosensory evoked potentials and myogenic MEPs requires critical anesthetic choices for INM. The management of the physiologic milieu is also important as central nervous system blood flow, intracranial pressure, blood rheology, temperature, and arterial carbon dioxide partial pressure produce alterations in the responses consistent with the support of neural functioning. Finally, the management of pharmacologic neuromuscular blockade is critical to myogenic MEP recording in which some blockade may be desirable for surgery but excessive blockade may eliminate responses. A close working relationship of the monitoring team, the anesthesiologist, and the surgeon is key to the successful conduct and interpretation of INM.

With the increased use of intraoperative monitoring of the central nervous system (CNS) has come a need for better understanding of the effects of anesthetic agents on intraoperative recordings. The commonly used anesthetic agents and their effects on intraoperative electroencephalography (EEG) and evoked potentials (EP) are discussed. Halogenated inhalational anesthetics produce dose-related reduction in EEG amplitude and frequency after an initial activation. They also produce dose-related decreases in amplitude and increases in latency of sensory evoked potentials (SEP) that are most marked in cortically generated components. Subcortical, spinal, and peripheral evoked responses are less affected. Responses in the motor pathways are recordable in the epidural space; however, the relative contributions of sensory and motor tracts may be changed when both are present. Muscle responses are easily suppressed after spinal and motor cortex stimulation, probably by anesthetic effect at the anterior horn cells of the spinal cord. Intravenous analgesic agents (opioids, ketamine) are associated with less marked changes in EEG and evoked responses, with some increases in amplitude of cortically generated SEP caused by ketamine. Intravenous sedative-hypnotic drugs (droperidol, barbiturates, benzodiazepines, etomidate, propofol) produce dose-related depression of the EEG after initial activation and dose-related depression of evoked responses to a lesser extent than do the inhalation agents. Etomidate is associated with amplitude enhancement of EEG and cortically generated SEP. Muscle relaxants have minimal effect on the EEG and SEP. Their use, however, may alter muscle recordings from motor tract stimulation. These effects and their relevance to the choice of agents for specific monitoring techniques are discussed.

The use of processed electroencephalography (EEG) using a simple frontal lead system has been made available for assessing the impact of anesthetic medications during surgery. This review discusses the basic principles behind these devices. The foundations of anesthesia monitoring rest on the observations of Guedel with ether that the depth of anesthesia relates to the cortical, brainstem and spinal effects of the anesthetic agents. Anesthesiologists strive to have a patient who is immobile, is unconscious, is hemodynamically stable and who has no intraoperative awareness or recall. These anesthetic management principles apply today, despite the absence of ether from the available anesthetic medications. The use of the EEG as a supplement to the usual monitoring techniques rests on the observation that anesthetic medications all alter the synaptic function which produces the EEG. Frontal EEG can be viewed as a surrogate for the drug effects on the entire central nervous system (CNS). Using mathematical processing techniques, commercial EEG devices create an index usually between 0 and 100 to characterize this drug effect. Critical aspects of memory formation occur in the frontal lobes making EEG monitoring in this area a possible method to assess risk of recall. Integration of processed EEG monitoring into anesthetic management is evolving and its ability to characterize all of the anesthetic effects on the CNS (in particular awareness and recall) and improve decision making is under study.

Anesthesia for pediatric patients undergoing surgery where IONM is being performed is consistent with the practice and principles of anesthesia for adults. Although PRIS has not caused major alterations in most patients, concern has modified the practice of some anesthesiologists.